Impanzees. Mol Biol Evol. 1993;10:512?6. Adachi A, Gendelman HE, Koenig S, Folks
Impanzees. Mol Biol Evol. 1993;10:512?6. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986;59:284?1. Iwatani Y, Song SK, Wang L, Planas J, Sakai H, Ishimoto A, Cloyd MW. Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release. J Gen Virol. 1997;78(Pt 4):841?. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39:783?1. Vodicka MA, Goh WC, Wu LI, Rogel ME, Bartz SR, Schweickart VL, Raport CJ, Emerman M. Indicator cell lines for Necrosulfonamide price Detection of primary strains of human and simian immunodeficiency viruses. Virology. 1997;233:193?. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol. 1992;66:2232?. Pathak VK, Temin HM. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28300835 replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A. 1990;87:6019?3. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004;4:868?7. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol. 2004;14: 1392?. Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, Siliciano RF. G?A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol. 2005;79:1975?980. Yu Q, Konig R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minusstrand deamination of the HIV genome. Nat Struct Mol Biol. 2004;11:435?2. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418:646?0. Janini M, Rogers M, Birx DR, McCutchan FE. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol. 2001;75:7973?6. Rose PP, Korber BT. Detecting hypermutations in viral sequences with an emphasis on G ? A hypermutation. Bioinformatics. 2000; 16:400?01.45. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673?0. 46. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993;67:6365?8. 47. Davey Jr RT, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R, Natarajan V, Lempicki RA, Adelsberger JW, Miller KD, et al. HIV-1 and PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/29069523 T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A. 1999; 96:15109?4. 48. Siliciano JD, Siliciano RF. A long-term latent reservoir for HIV-1: discovery and clinical implications. J Antimicrob Chemother. 2004;54.